Answers are grounded in this paper and cite their sources.
Corticosteroids are widely used for the treatment of coronavirus disease (COVID)-19. Genetic polymorphisms of the glucocorticoid receptor, metabolizing enzymes, or transporters may affect treatment response to dexamethasone. This study aimed to evaluate the association of the glucocorticoid pathway polymorphisms with the treatment response and short-term outcomes in patients with severe COVID-19.
No takes yet. Share an insight, caveat, or question.
Štampar et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: